Hence, our aims were to characterize a group of Brazilian patients with early onset breast cancer for BRCA1 and BRCA2 germline mutations, as well as for somatic SNVs arising in luminal subtype tumors. This evidence concerns the gene BRCA2 and breast carcinoma.